A PHASE I/II TRIAL OF TRANSURETHRAL SURGERY COMBINED WITH CONCURRENT CISPLATIN, 5-FLUOROURACIL AND TWICE DAILY RADIATION FOLLOWED BY SELECTIVE BLADDER PRESERVATION IN OPERABLE PATIENTS WITH MUSCLE INVADING BLADDER CANCER
- 1 November 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (5) , 1673-1677
- https://doi.org/10.1016/s0022-5347(01)62379-6
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Bladder preservation by combined modality therapy for invasive bladder cancer.Journal of Clinical Oncology, 1997
- 1000 Organ conservation in bladder cancerEuropean Journal Of Cancer, 1995
- Organ-sparing treatment of advanced bladder cancer: A 10-year experienceInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Selective Bladder Preservation by Combination Treatment of Invasive Bladder CancerNew England Journal of Medicine, 1993
- Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.Journal of Clinical Oncology, 1993
- Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of rtog protocol 85-12International Journal of Radiation Oncology*Biology*Physics, 1993
- Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1992
- A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladderThe British Journal of Radiology, 1992
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992
- Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgeryJAMA, 1987